Statistics
Total Visits
Views | |
---|---|
Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent(legacy) | 142 |
Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent(legacy) | 74 |
Total Visits per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent | 0 | 4 | 2 | 0 | 0 | 4 | 11 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 57 |
China | 16 |
Netherlands | 8 |
Vietnam | 6 |
Australia | 5 |
Hong Kong SAR China | 3 |
Singapore | 3 |
Germany | 1 |
Spain | 1 |
France | 1 |
Top City Views
Views | |
---|---|
Ashburn | 19 |
Rotterdam | 8 |
Fairfield | 6 |
Hanoi | 6 |
Hanover | 6 |
Beijing | 5 |
Zhengzhou | 5 |
Kaleen | 4 |
Cambridge | 3 |
Central | 3 |